Evaluating the predictive value of endoscopic findings for residual colorectal cancer following neoadjuvant combination immunotherapy

Figure 1 Evaluation of endoscopic efficacy after neoadjuvant combination immunotherapy for colorectal cancer. A: Representative images of complete response before and after treatment; B: Representative images of near-complete response before and after treatment; C: Representative images of partial response before and after treatment; D: Representative images of stable disease before and after treatment.

Figure 2 Flowchart of patient selection. CRC: Colorectal cancer; ICI: Immune checkpoint inhibitor; dMMR: Deficient mismatch repair; pMMR: Proficient mismatch repair.